Close Sidebar
Nordic Life Science
Now Reading
Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials
Search for content, post, videos
Search for content, post, videos
Advertisement

Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials

March 15, 2023
1066 Views
Novo Nordisk has announced it is lowering the US list prices of several insulin products by up to 75% for people living with type 1 and type 2 diabetes. Products include both pre-filled pens and vials of basal (long-acting), bolus (short-acting) and pre-mix insulins, specifically Levemir, Novolin
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.

Malin Otmani

Related Posts

July 18, 2023

The company's presence in Copenhagen positions Controlant to tap into Denmark's strong life-science ecosystem, get closer to its customers, access a large pool of skilled professionals, and more closely collaborate with technology and industry partners, it states. Controlant is on a growth journeAlready a subscriber Login You have read all…

magnus-hansson-neurovive
January 24, 2017

NeuroVive Pharmaceutical has signed a preclinical collaboration agreement with the Children's Hospital of Philadelphia (CHOP) and Marni J. Falk, M.D., a US opinion leader in the mitochondrial medicine field. Dr. Falk's research team at CHOP will evaluate compounds from NeuroVive's research prograAlready a subscriber Login You have read all your…

December 19, 2019

Nordic Nanovector's research and development project Nanoyield has received a non-dilutive funding of NOK 12 million (USD 1.3 million) from the Norwegian Research Council (Forskningsrådet). The Nanoyield project is aimed at optimising the production yield of Nordic Nanovector’s CD37-targeting Already a subscriber Login You have read all your free articles,…

May 24, 2023

On behalf of the Swedish government, the Swedish innovation agency Vinnova has decided on funding of an innovation cluster for commercialization, competence development and production capacity for advanced therapies. The new cluster will serve as a national infrastructure and competence node for Already a subscriber Login You have read all…